Researchers developed a simple injection that may support the heart during the vulnerable weeks after a heart attack. The treatment is given into skeletal muscle and prompts the body to release ANP, a natural hormone that reduces stress on the heart.
A study of the work in Science showed that a single dose produced ANP for several weeks. The injection uses self-amplifying RNA (saRNA), a technology related to some modern vaccines, so muscle cells make extra ANP for a limited time and the hormone travels to the heart to help repair.
The researchers say the shot could reduce scarring, preserve healthy heart muscle, improve pumping function and lower long-term complications. Before human trials, the team will test safety, timing and dosing.
Difficult words
- vulnerable — easily harmed or needing protection
- skeletal muscle — muscle attached to bones used for movement
- hormone — chemical from the body that controls activity
- self-amplifying RNA — RNA that makes more copies inside cells
- scar — mark left on tissue after injury healsscarring
- preserve — keep something in its original or good condition
Tip: hover, focus or tap highlighted words in the article to see quick definitions while you read or listen.
Discussion questions
- How could a short-term injection that increases ANP change recovery after a heart attack for patients?
- What safety, timing, or dosing concerns should researchers check before they try this treatment in people?
- Would being treated by an injection into muscle feel more acceptable than a treatment given directly to the heart? Why or why not?
Related articles
Engineered antibodies could block cytomegalovirus
A research team created changed antibodies that stop human cytomegalovirus from disabling immune responses. Lab tests show the antibodies reduce virus spread, but researchers say more testing is needed before they can be used in people.
New AI tools for tuberculosis shown at lung health conference
Researchers presented four new AI approaches for detecting and monitoring TB at the Union World Conference on Lung Health in Copenhagen (18–21 November). The tools include breath analysis, cough screening, vulnerability mapping and a chest X‑ray tool for children.
Psychedelics change blood-flow signals in brain imaging
Researchers at Washington University found that psychedelics acting on serotonin can disrupt the normal link between neuronal activity and blood flow in mice. Similar effects appeared with psilocybin and in reanalyzed human fMRI data.
Low-cost cooling could help Bangladesh garment workers
A University of Sydney study, published in The Lancet Planetary Health on Monday (20 October), tested simple low-cost cooling in a chamber that mimicked extreme factory heat. Fans and water partly restored productivity; a reflective roof cut indoor temperature by 2.5°C.